ICG1_ed-5 Publications of the last five years

  1. Moskaliuk V.S., Kozhemyakina R.V., Bazovkina D.V., Terenina E., Khomenko T.K., Volcho K.P., Salakhutdinov N.F., Kulikov A.V., Naumenko V.S., Kulikova E. On an association between fear-induced aggression and striatal-enriched protein tyrosine phosphatase (STEP) in the brain of Norway rats // Biomedicine & Pharmacotherapy, 2022, 147, 112667.
  2. Abdullina AA, Vasileva EV, Kulikova EA, Naumenko VS, Plyusnina AV, Gudasheva TA, Kovalev GI, Seredenin SB. The neuropeptide cycloprolylglycine produces antidepressant-like effect and enhances BDNF gene expression in the mice cortex // J Psychopharmacol., 2022. 36(2):214-222. doi: 10.1177/02698811211069101.
  3. Rodnyy A.Ya, Kondaurova E.M., Bazovkina D.V., Kulikova E.A., Ilchibaeva T.V., Kovetskaya A.I., Baraboshkina I.A., Bazhenova E. Yu., Popova N.K., Naumenko V.S. Serotonin 5-HT7 receptor overexpression in raphe nuclei area produces antidepressive effect and affects brain serotonin system in male mice // J Neurosci Res., 2022. (in press).
  4. Kondaurova E.M., Bazovkina D.V., Bazhenova E.Yu., Naumenko V.S. Effect of central administration of brain-derived neurotrophic factors (BDNF) on behavior, brain monoamines and their metabolites in the B6.CBA-D13Mit76B and B6.CBA-D13Mit76C recombinant mouse lines differed by 5-HT1A receptor functioning // Int J Mol Sci. 2021; 22(21):11987. doi: 10.3390/ijms222111987.
  5. Kondaurova E.M., Plyusnina A.V., Ilchibaeva T.V., Eremin D.V., Rodnyy A.Ya., Grygoreva Yu.D., Naumenko V.S. Effects of a CC2D1A/Freud-1 Knockdown in the Hippocampus on Behavior, the Serotonin System, and BDNF // Int. J. Mol. Sci. 2021, 22, 13319. https://doi.org/10.3390/ijms222413319.
  6. Sonnenberg S.B., Rauer J., Göhr C., Gorinski N., Schade S.K., Galil D.A., Naumenko V., Zeug A., Bischoff S.C., Ponimaskin E., Guseva D. 5-HT4 receptor interacts with adhesion molecule L1 to modulate morphogenic signaling in neurons // J Cell Sci. 2021. 134(4):jcs doi: 10.1242/jcs.249193.
  7. Kondaurova E.M., Rodnyy A.Ya, Ilchibaeva T.V., Tsybko A.S., Eremin D.V., Antonov E.V., Popova N.K. Naumenko V.S. Genetic background underlying 5-HT1A receptor functioning affects the response to fluoxetine // Int J Mol Sci. 2020, 21:8784; doi:10.3390/ijms21228784
  8. Popova N.K., Kulikov A.V., Naumenko V.S. Spaceflight and brain plasticity: Spaceflight effects on regional expression of neurotransmitter systems and neurotrophic factors encoding genes // Neurosci Biobehav Rev. 2020. 119:396-405.
  9. Tsybko A.S., Ilchibaeva T.V., Filimonova E.A., Eremin D.V., Popova N.K., Naumenko V.S. The chronic treatment with 5-HT2A receptor agonists affects the behavior and the BDNF system in mice // Neurochem Res. 2020. 45(12):3059-3075.
  10. Popova N.K., Ilchibaeva T.V., Antonov E.V., Pershina A.V., Bazovkina D.V., Naumenko V.S. On the interaction between BDNF and serotonin systems: the effects of long-term ethanol consumption in mice // Alcohol. 2020. 87:1-15.
  11. Gorinski N, Bijata M, Prasad S, Wirth A, Abdel Galil D, Zeug A, Bazovkina D, Kondaurova E, Kulikova E, Ilchibaeva T, Zareba-Koziol M, Papaleo F, Scheggia D, Kochlamazashvili G, Dityatev A, Smyth I, Krzystyniak A, Wlodarczyk J, Richter DW, Strekalova T, Sigrist S, Bang C, Hobuß L, Fiedler J, Thum T, Naumenko VS, Pandey G, Ponimaskin E. Attenuated palmitoylation of serotonin receptor 5-HT1A affects receptor function and contributes to depression-like behaviors // Nat Commun. 2019; 10(1):3924.
  12. Popova N.K., Naumenko V.S. Neuronal and behavioral plasticity: the role of serotonin and BDNF systems tandem // Expert Opin Ther Targets. 2019. 23(3):227–239.
  13. Chadaeva I., Petr Ponomarenko P., Rasskazov D., Sharypova E., Kashina E., Kleshchev M., Ponomarenko M., Naumenko V., Savinkova L., Kolchanov N., Osadchuk L., and Osadchuk A. Natural selection equally supports the human tendencies in subordination and domination: a genome-wide study with in silico confirmation and in vivo validation in mice // Front Genet. 2019. 10:73.
  14. Naumenko V.S., Ponimaskin E. Palmitoylation as a Functional Regulator of Neurotransmitter Receptors // Neural Plasticity. 2018:5701348.
  15. Ilchibaeva T.V., Tsybko A.S., Kozhemyakina R.V., Kondaurova E.M., Popova N.K., Naumenko V.S. Genetically defined fear-induced aggression: focus on BDNF and its receptors // Behav. Brain Res. 2018;343:102-110.
  16. Kulikov A.V., Gainetdinov R.R., Ponimaskin E., Kalueff A.V., Naumenko V.S., Popova N.K. Interplay between the key proteins of serotonin system in SSRI antidepressants efficacy // Expert Opinion On Therapeutic Targets. 2018;22(4):319-330..
  17. Knyazev G.G., Savostyanov A.N., Bocharov A.V., Bazovkina D.V., Proshina E.A. Resting State Networks Mediate the Effect of Genotype by Environment Interaction on Mental Health // Neuroscience. 2018;369:139-151.
  18. Kulikova E.A., Kulikov A.V. Kaiso Protein in the Regulation of Brain and Behavior // Curr Protein Pept Sci. 2018;19(7):692-698.
  19. Kulikova E.A., Khotskin N.V., Illarionova N.B., Sorokin I.E., Bazhenova E.Y., Kondaurova E.M., Volcho K.P., Khomenko T.M., Salakhutdinov N.F., Ponimaskin E., Naumenko V.S., Kulikov A.V. Inhibitor of striatal-enriched protein tyrosine phosphatase, 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride (TC-2153), produces antidepressant-like effect and decreases functional activity and protein level of 5-HT2A receptor in the brain // Neuroscience. 2018;394:220-231.
  20. Kondaurova E., Antonov Y., Pershina A., Bazhenova E., Bazovkina D., Popova N. Acute stress effect on hypothalamus BDNF expression, monoamines levels and adrenal catecholamines in mouse lines differed by 5-HT1A receptor function // European Neuropsychopharmacology. 2018;29:S249-S250.
  21. Voronova I., Khramova G., Bazovkina D., Kulikov A. Involvement of serotonin2A (5-HT2A) receptor and terminal fragment of chromosome 13 in the development of hypothermia in lipopolysaccharide (LPS)-treated mice // European Neuropsychopharmacology. 2018;29:S277.
  22. Bazovkina D., Pershina A., Fursenko D., Khotskin N., Kulikova E., Bazhenova E., Kulikov A. Role of tumor necrosis factor gene in acute lipopolysacharide effect on behavior, brain expression of interleukins and brain serotonin system in mice // European Neuropsychopharmacology. 2018;29:S464.
  23. Kulikova E., Khotskin N., Bazhenova E., Sergiyenko V., Fursenko D., Sorokin I., Kolotygin I., Khotskina A., Kulikov A. Alterations in the expression and activity of STEP in the mouse brain induced by genetically defined obesity and lipopolysaccharide (LPS) administration // European Neuropsychopharmacology. 2018;29:S50-S51.
  24. Kulikov A., Sinyakova N., Kulikova E., Evglevsky N., Kolotygin I., Volcho K., Salakhutdinov N., Kulikov V., Romaschenko A., Moshkin M. Effects of acute and chronic treatment of STEP inhibitor, TC-2153, on the nervous system and behaviour of zebrafish (Danio rerio) // European Neuropsychopharmacology. 2018;S198-S199.
  25. Tsybko A., Ilchibaeva T., Khotskin N., Naumenko V., Popova N. The effect of atypical antipsychotic drugs on the neurotrophic factors gene expression in the MPTP model of Parkinson’s disease // European Neuropsychopharmacology. 2018;29:S159-S160.
  26. Ilchibaeva T., Eremin D., Kozhemyakina R., Naumenko V., Tsybko A. Implication of the brain dopamine system in the regulation of genetically-defined aggressive behavior in rats // European Neuropsychopharmacology. 2018;29:S556-S557.
  27. Khotskin N.V., Plyusnina A.V., Kulikova E.A., Bazhenova E.Yu, Fursenko D.V., Sorokin I.E., Kolotygin I., Mormede P., Terenina E.E., Shevelev O.B., Kulikov A.V. On association of the lethal yellow (AY ) mutation in the agouti gene with the alterations in mouse brain and behavior. Behavioural Brain Research. 2018; 359:446-456.
  28. Kulikova EA, Kulikov AV. Kaiso protein in the regulation of brain and behavior // Curr Protein Pept Sci. 2018;19(7):692-698.
  29. Kulikova E.A., Bazovkina D.V., Antonov Y.V., Akulov A.E., Kulikov A.V., Kondaurova E.M. Alteration of the brain morphology and the response to the acute stress in the recombinant mouse lines with different predisposition to catalepsy // Neuroscience Research. 2017;117:14-21.
  30. Bazhenova E.Y., Bazovkina D.V., Kulikova E.A., Fursenko D.V., Khotskin N.V., Lichman D.V., Kulikov A.V. C1473G polymorphism in mouse tryptophan hydroxylase-2 gene in the regulation of the reaction to emotional stress // Neuroscience Letters. 2017;640:105–110.
  31. Bazhenova E.Y., Sinyakova N.A., Kulikova E.A., Kazarinova I.A., Bazovkina D.V., Gainetdinov R.R., Kulikov A.V. No effect of C1473G polymorphism in the tryptophan hydroxylase 2 gene on the response of the brain serotonin system to chronic fluoxetine treatment in mice // Neuroscience Letters. 2017;V.653:264–268.
  32. Tsybko A.S., Ilchibaeva T.V., Popova N.K. Role of glial cell line-derived neurotrophic factor in the pathogenesis and treatment of mood disorders // Rev Neurosci. 2017;28(3):219-233.
  33. Kulikova E.A., Volcho K.P., Salakhutdinov N.F., Kulikov A.V. Benzopentathiepine derivative, 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride (TC-2153), as a promising antidepressant of new generation  // Lett Drug Des Discov. 2017;14(8):974-984.
  34. Kulikova E.A., Kulikov A.V. Striatal-enriched tyrosine protein phosphatase (STEP) in the mechanisms of depressive disorders // Curr Protein Pept Sc. 2017;18(11):1152-1162.
  35. Ilchibaeva T.V., Tsybko A.S., Kozhemyakina R.V., Konoshenko M.Y., Popova N.K., Naumenko V.S. The relationship between different types of genetically defined aggressive behavior // J Ethol. 2017;35(1):75–81.
  36. Knyazev G.G., Bazovkina D.V., Savostyanov A.N., Naumenko V.S., Kuznetsova V.B., Proshina EA. Suppression mediates the effect of 5-HTTLPR by stress interaction on depression // Scand J Psychol. 2017;58(5):373-378.
  37. Knyazev GG, Savostyanov AN, Bocharov AV, Bazovkina DV, Proshina EA. Resting State Networks Mediate the Effect of Genotype by Environment Interaction on Mental Health // Neurosci. 2017;369:139-151.